Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients

Type 2 diabetes mellitus affects 15% of the population around the world, causing health complications and increasing the treatment’s costs. Being a chronic outpatient treatment disease, patient compliance is higher importance to achieve therapeutic success. The present study measure the cost effecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maciel, Olga, Vera, Zully, Marín, Gustavo Horacio, Maidana, Mabel, Samaniego, Lourdes, Lugo, Gladys, Mastroianni, Patricia
Formato: Articulo
Lenguaje:Inglés
Publicado: 2018
Materias:
Medicina
Cost-effectiveness
Type 2 diabetes
Adherence
Pharmacotherapy compliance
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/99653
https://ri.conicet.gov.ar/11336/84321
https://www.rjpbcs.com/pdf/2018_9(5)/[230].pdf
Aporte de:
SEDICI (UNLP) de Universidad Nacional de La Plata
id I19-R120-10915-99653
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Medicina
Cost-effectiveness
Type 2 diabetes
Adherence
Pharmacotherapy compliance
spellingShingle Medicina
Cost-effectiveness
Type 2 diabetes
Adherence
Pharmacotherapy compliance
Maciel, Olga
Vera, Zully
Marín, Gustavo Horacio
Maidana, Mabel
Samaniego, Lourdes
Lugo, Gladys
Mastroianni, Patricia
Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
topic_facet Medicina
Cost-effectiveness
Type 2 diabetes
Adherence
Pharmacotherapy compliance
description Type 2 diabetes mellitus affects 15% of the population around the world, causing health complications and increasing the treatment’s costs. Being a chronic outpatient treatment disease, patient compliance is higher importance to achieve therapeutic success. The present study measure the cost effectiveness of the compliance of this disease. An observational, cross-sectional, pharmaco-economic study was performed. A National program to stimulate treatment adherence was taken as intervention stage. Compliance was measure by Morisky-Green test and details of the events in each patient's health (medication, consultations, hospitalization and concomitant treatments) were used to determinate the direct costs for Ministry of Public Health. Effectiveness was measured by percentage of glycated hemoglobin (HbA1c). The sample obtained was 55 patients, which were grouped into 31 compliant and 24 non-compliant. The costeffectiveness of compliance was 466 US$ / compliant effective patient and 1,807 US$ / non-compliant effective patient. The cost-effectiveness of hypoglycemic drug therapy compliance is significantly lower (almost 4 times) than non-compliance. Type 2 Diabetes Mellitus patients that have no therapy adherence are not able to maintain protective levels of HbA1c. In addition, for the Ministry of Public Health, the lack of adherence requires more budget to accomplished the health goals.
format Articulo
Articulo
author Maciel, Olga
Vera, Zully
Marín, Gustavo Horacio
Maidana, Mabel
Samaniego, Lourdes
Lugo, Gladys
Mastroianni, Patricia
author_facet Maciel, Olga
Vera, Zully
Marín, Gustavo Horacio
Maidana, Mabel
Samaniego, Lourdes
Lugo, Gladys
Mastroianni, Patricia
author_sort Maciel, Olga
title Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
title_short Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
title_full Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
title_fullStr Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
title_full_unstemmed Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
title_sort cost-effectiveness of drug compliance in type 2 diabetes mellitus patients
publishDate 2018
url http://sedici.unlp.edu.ar/handle/10915/99653
https://ri.conicet.gov.ar/11336/84321
https://www.rjpbcs.com/pdf/2018_9(5)/[230].pdf
work_keys_str_mv AT macielolga costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
AT verazully costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
AT maringustavohoracio costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
AT maidanamabel costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
AT samaniegolourdes costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
AT lugogladys costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
AT mastroiannipatricia costeffectivenessofdrugcomplianceintype2diabetesmellituspatients
bdutipo_str Repositorios
_version_ 1764820493544718338

Ejemplares similares